From Vision to Action
Impact Through Collaborative Implementation
Combating rheumatic heart disease through awareness.
Partner Organisations:
Stanford Biodesign and State Government of Uttar Pradesh, India.
Rheumatic Heart Disease (RHD) is a preventable yet serious condition affecting children in underserved regions like Uttar Pradesh. To address this, Stanford Biodesign launched an awareness and screening program, educating communities and equipping healthcare workers to detect and manage RHD early.
The initiative focused on bridging the awareness gap by collaborating with local schools, healthcare providers, and community leaders to highlight the connection between untreated streptococcal infections and heart disease. Through portable echocardiography screenings, the program enabled early detection in schoolchildren, ensuring timely medical intervention. Local doctors and health workers were trained to diagnose and prevent disease progression with penicillin prophylaxis.
The impact was significant—previously undiagnosed cases were identified, and communities became proactive in seeking early treatment. By integrating medical innovation with grassroots education, Stanford Biodesign has created a sustainable model for reducing RHD in Uttar Pradesh, saving young lives through awareness and early action.
Initiative for breast cancer screening in Uttar Pradesh and Karnataka
Partner Organisations:
State Governments of Uttar Pradesh and Karnataka, India.
Breast cancer is the most common cancer among women in India, with over 200,000 new cases diagnosed annually. However, nearly 50% of cases are detected at later stages, reducing survival rates. To address this, IndusSetu, in collaboration with a leading healthcare major and the state governments of Uttar Pradesh and Karnataka, is launching a breast cancer screening program focused on early detection, starting in Deoria district.
The program will use advanced screening technologies to reach underserved populations, ensuring timely diagnosis and treatment referrals. By training local healthcare workers and leveraging mobile screening units, the initiative aims to improve early detection rates, ultimately increasing survival chances by up to 90%. With breast cancer cases rising in India, this initiative is a crucial step toward accessible, preventive healthcare for women in these states.
This program and learnings from it will lay the initial foundation for a similar program in the Selma province under the Benaras-Selma bridges initiative.
Advancing AI and Semiconductor innovations in HealthTech
Partner Organisations: SEMI
IndusSetu and SEMI have partnered to drive AI-powered semiconductor innovation in Indian healthcare, a collaboration showcased at SEMICON India 2024. With insights from leaders like Vinod Dham and Ajit Manocha, the initiative aims to enhance medical diagnostics, accessibility, and affordability.
Key Focus Areas:
-
Healthcare AI & Semiconductor Integration: Enabling advanced diagnostics and real-time monitoring.
-
Regulatory & Governmental Backing: Insights from U.S. FDA Commissioner Dr. Robert Califf and MeitY Secretary S Krishnan reinforce policy support.
-
Make-in-India & Global Expansion: Aligning with India’s semiconductor manufacturing goals, strengthening health-tech R&D.
By merging SEMI’s global expertise with IndusSetu’s footprint in India and the Silicon Valley ecosystem, this partnership is set to create bridges of collaboration in the Ithe healthcare ecosystem, ensuring smarter, scalable, and accessible medical solutions.
%20Logo.png)
2024 IndusSetu Global Foundation